References
- Jahnke K, Thiel E, Martus P, et al. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol. 2006;80:159–165.
- Provencher S, Ferlay C, Alaoui-Slimani K, et al. Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series. Hematol Oncol. 2011;29:10–16.
- Kim JE, Yoon DH, Kim S, et al. Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma. Korean J Hematol. 2012;47:60–66.
- Baehring JM, Damek D, Martin EC, et al. Neurolymphomatosis. Neuro-oncology. 2003;5:104–115.
- Borit A, Altrocchi PH. Recurrent polyneuropathy and neurolymphomatosis. Arch Neurol. 1971;24:40–49.
- Trelles JO, Trelles L. [Human peripheral neurolymphomatosis]. Rev Neurol (Paris). 1983;139:703–714.
- Vallat JM, De Mascarel HA, Bordessoule D, et al. Non-Hodgkin malignant lymphomas and peripheral neuropathies–13 cases. Brain. 1995;118:1233–1245.
- Ferreri AJ, Cwynarski K, Pulczynski E, et al. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016;3:e217–e227.
- Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an international primary CNS lymphoma collaborative group report. Blood. 2010;115:5005–5011.
- Batchelor T, Carson K, O'Neill A, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol. 2003;21:1044–1049.
- Pels H, Schulz H, Schlegel U, et al. Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literature. Onkologie. 2003;26:351–354.
- Rubenstein JL, Combs D, Rosenberg J, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 2003;101:466–468.
- Gray JR, Wallner KE. Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia. Int J Radiat Oncol Biol Phys. 1990;19:439–444.
- Shenkier TN. Unusual variants of primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005;19:651–664.